Gross profit decreased 0.9%
Gross profit changed -0.9% from the comparable as-filed period.
$10.6M→$10.5M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LAB financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 70.2%
Cash & equivalents changed +70.2% from the comparable as-filed period.
$158.6M→$270.0M2 prior comparisons
Gross margin moved 357 bp higher
Gross margin changed +357 basis points from the comparable as-filed period.
48.84%→52.40%3 prior comparisons
Inventory decreased 29.2%
Inventory changed -29.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$24.2M→$17.1M4 prior comparisons
Net income increased 20.0%
Net income changed +20.0% from the comparable as-filed period.
-$33.5M→-$26.8M2 prior comparisons
Operating margin moved 820 bp lower
Operating margin changed -820 basis points from the comparable as-filed period.
-118.08%→-126.28%3 prior comparisons
Research & development decreased 68.2%
Research & development changed -68.2% from the comparable as-filed period.
$6.2M→$2.0M3 prior comparisons
Selling, general & administrative decreased 41.7%
Selling, general & administrative changed -41.7% from the comparable as-filed period.
$28.1M→$16.4M3 prior comparisons
Stock-based compensation decreased 24.6%
Stock-based compensation changed -24.6% from the comparable as-filed period.
$5.4M→$4.1M3 prior comparisons
Revenue decreased 7.6%
Revenue changed -7.6% from the comparable as-filed period.
$21.8M→$20.1M3 prior comparisons
Operating income increased 1.2%
Operating income changed +1.2% from the comparable as-filed period.
-$25.7M→-$25.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.